Form 8-K - Current report:
SEC Accession No. 0000950170-25-006495
Filing Date
2025-01-17
Accepted
2025-01-17 09:01:20
Documents
11
Period of Report
2025-01-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K xene-20250117.htm   iXBRL 8-K 45738
  Complete submission text file 0000950170-25-006495.txt   166922

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT xene-20250117.xsd EX-101.SCH 30841
13 EXTRACTED XBRL INSTANCE DOCUMENT xene-20250117_htm.xml XML 4684
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 25537144
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)